βIII-tubulin regulates breast cancer metastases to the Brain

Deepak Kanojia, Ramin A. Morshed, Lingjiao Zhang, Jason M. Miska, Jian Qiao, Julius W. Kim, Peter Pytel, Irina V. Balyasnikova, Maciej S. Lesniak*, Atique U. Ahmed

*Corresponding author for this work

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Brain metastases occur in about 10% to 30% of breast cancer patients, which culminates in a poor prognosis. It is, therefore, critical to understand the molecular mechanisms underlying brain metastatic processes to identify relevant targets. We hypothesized that breast cancer cells must express brain-associated markers that would enable their invasion and survival in the brain microenvironment. We assessed a panel of brainpredominant markers and found an elevation of several neuronal markers (βIII-tubulin, Nestin, and AchE) in brain metastatic breast cancer cells. Among these neuronal predominant markers, in silico analysis revealed overexpression of bIII-tubulin (TUBB3) in breast cancer brain metastases (BCBM) and its expression was significantly associated with distant metastases. TUBB3 knockdown studies were conducted in breast cancer models (MDA-Br, GLIM2, and MDA-MB-468), which revealed significant reduction in their invasive capabilities. MDA-Br cells with suppressed TUBB3 also demonstrated loss of key signaling molecules such as β3 integrin, pFAK, and pSrc in vitro. Furthermore, TUBB3 knockdown in a brain metastatic breast cancer cell line compromised its metastatic ability in vivo, and significantly improved survival in a brain metastasis model. These results implicate a critical role of TUBB3 in conferring brain metastatic potential to breast cancer cells.

Original languageEnglish (US)
Pages (from-to)1152-1161
Number of pages10
JournalMolecular Cancer Therapeutics
Volume14
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Tubulin
Breast Neoplasms
Neoplasm Metastasis
Brain
Nestin
Survival
Integrins
Brain Neoplasms
Computer Simulation
Cell Line

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kanojia, D., Morshed, R. A., Zhang, L., Miska, J. M., Qiao, J., Kim, J. W., ... Ahmed, A. U. (2015). βIII-tubulin regulates breast cancer metastases to the Brain. Molecular Cancer Therapeutics, 14(5), 1152-1161. https://doi.org/10.1158/1535-7163.MCT-14-0950
Kanojia, Deepak ; Morshed, Ramin A. ; Zhang, Lingjiao ; Miska, Jason M. ; Qiao, Jian ; Kim, Julius W. ; Pytel, Peter ; Balyasnikova, Irina V. ; Lesniak, Maciej S. ; Ahmed, Atique U. / βIII-tubulin regulates breast cancer metastases to the Brain. In: Molecular Cancer Therapeutics. 2015 ; Vol. 14, No. 5. pp. 1152-1161.
@article{cfefc8f8481f42499e1f3eef4c8351f5,
title = "βIII-tubulin regulates breast cancer metastases to the Brain",
abstract = "Brain metastases occur in about 10{\%} to 30{\%} of breast cancer patients, which culminates in a poor prognosis. It is, therefore, critical to understand the molecular mechanisms underlying brain metastatic processes to identify relevant targets. We hypothesized that breast cancer cells must express brain-associated markers that would enable their invasion and survival in the brain microenvironment. We assessed a panel of brainpredominant markers and found an elevation of several neuronal markers (βIII-tubulin, Nestin, and AchE) in brain metastatic breast cancer cells. Among these neuronal predominant markers, in silico analysis revealed overexpression of bIII-tubulin (TUBB3) in breast cancer brain metastases (BCBM) and its expression was significantly associated with distant metastases. TUBB3 knockdown studies were conducted in breast cancer models (MDA-Br, GLIM2, and MDA-MB-468), which revealed significant reduction in their invasive capabilities. MDA-Br cells with suppressed TUBB3 also demonstrated loss of key signaling molecules such as β3 integrin, pFAK, and pSrc in vitro. Furthermore, TUBB3 knockdown in a brain metastatic breast cancer cell line compromised its metastatic ability in vivo, and significantly improved survival in a brain metastasis model. These results implicate a critical role of TUBB3 in conferring brain metastatic potential to breast cancer cells.",
author = "Deepak Kanojia and Morshed, {Ramin A.} and Lingjiao Zhang and Miska, {Jason M.} and Jian Qiao and Kim, {Julius W.} and Peter Pytel and Balyasnikova, {Irina V.} and Lesniak, {Maciej S.} and Ahmed, {Atique U.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1158/1535-7163.MCT-14-0950",
language = "English (US)",
volume = "14",
pages = "1152--1161",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

βIII-tubulin regulates breast cancer metastases to the Brain. / Kanojia, Deepak; Morshed, Ramin A.; Zhang, Lingjiao; Miska, Jason M.; Qiao, Jian; Kim, Julius W.; Pytel, Peter; Balyasnikova, Irina V.; Lesniak, Maciej S.; Ahmed, Atique U.

In: Molecular Cancer Therapeutics, Vol. 14, No. 5, 01.05.2015, p. 1152-1161.

Research output: Contribution to journalArticle

TY - JOUR

T1 - βIII-tubulin regulates breast cancer metastases to the Brain

AU - Kanojia, Deepak

AU - Morshed, Ramin A.

AU - Zhang, Lingjiao

AU - Miska, Jason M.

AU - Qiao, Jian

AU - Kim, Julius W.

AU - Pytel, Peter

AU - Balyasnikova, Irina V.

AU - Lesniak, Maciej S.

AU - Ahmed, Atique U.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Brain metastases occur in about 10% to 30% of breast cancer patients, which culminates in a poor prognosis. It is, therefore, critical to understand the molecular mechanisms underlying brain metastatic processes to identify relevant targets. We hypothesized that breast cancer cells must express brain-associated markers that would enable their invasion and survival in the brain microenvironment. We assessed a panel of brainpredominant markers and found an elevation of several neuronal markers (βIII-tubulin, Nestin, and AchE) in brain metastatic breast cancer cells. Among these neuronal predominant markers, in silico analysis revealed overexpression of bIII-tubulin (TUBB3) in breast cancer brain metastases (BCBM) and its expression was significantly associated with distant metastases. TUBB3 knockdown studies were conducted in breast cancer models (MDA-Br, GLIM2, and MDA-MB-468), which revealed significant reduction in their invasive capabilities. MDA-Br cells with suppressed TUBB3 also demonstrated loss of key signaling molecules such as β3 integrin, pFAK, and pSrc in vitro. Furthermore, TUBB3 knockdown in a brain metastatic breast cancer cell line compromised its metastatic ability in vivo, and significantly improved survival in a brain metastasis model. These results implicate a critical role of TUBB3 in conferring brain metastatic potential to breast cancer cells.

AB - Brain metastases occur in about 10% to 30% of breast cancer patients, which culminates in a poor prognosis. It is, therefore, critical to understand the molecular mechanisms underlying brain metastatic processes to identify relevant targets. We hypothesized that breast cancer cells must express brain-associated markers that would enable their invasion and survival in the brain microenvironment. We assessed a panel of brainpredominant markers and found an elevation of several neuronal markers (βIII-tubulin, Nestin, and AchE) in brain metastatic breast cancer cells. Among these neuronal predominant markers, in silico analysis revealed overexpression of bIII-tubulin (TUBB3) in breast cancer brain metastases (BCBM) and its expression was significantly associated with distant metastases. TUBB3 knockdown studies were conducted in breast cancer models (MDA-Br, GLIM2, and MDA-MB-468), which revealed significant reduction in their invasive capabilities. MDA-Br cells with suppressed TUBB3 also demonstrated loss of key signaling molecules such as β3 integrin, pFAK, and pSrc in vitro. Furthermore, TUBB3 knockdown in a brain metastatic breast cancer cell line compromised its metastatic ability in vivo, and significantly improved survival in a brain metastasis model. These results implicate a critical role of TUBB3 in conferring brain metastatic potential to breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84942162796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942162796&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-14-0950

DO - 10.1158/1535-7163.MCT-14-0950

M3 - Article

VL - 14

SP - 1152

EP - 1161

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 5

ER -

Kanojia D, Morshed RA, Zhang L, Miska JM, Qiao J, Kim JW et al. βIII-tubulin regulates breast cancer metastases to the Brain. Molecular Cancer Therapeutics. 2015 May 1;14(5):1152-1161. https://doi.org/10.1158/1535-7163.MCT-14-0950